Literature DB >> 9286086

Peptide bank generated by large-scale preparation of circulating human peptides.

P Schulz-Knappe1, M Schrader, L Ständker, R Richter, R Hess, M Jürgens, W G Forssmann.   

Abstract

Human hemofiltrate (HF) is a source for the purification of circulating regulatory peptides. HF is obtained in large quantities during treatment of patients suffering from chronic renal failure. We have developed a large-scale method for separating peptides from amounts up to 10,000 1 HF into 300 fractions in a standardized two-step procedure, employing cation-exchange separation, followed by reversed-phase chromatography. These fractions represent a peptide bank containing bioactive, desalted and lyophilized peptides of blood. Screening for and isolation of regulatory human peptides is simplified by using this peptide bank.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9286086     DOI: 10.1016/s0021-9673(97)00152-0

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  9 in total

1.  High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine.

Authors:  Harald Mischak; Bruce A Julian; Jan Novak
Journal:  Proteomics Clin Appl       Date:  2007-07-10       Impact factor: 3.494

2.  Structural and phylogenetic characterization of human SLURP-1, the first secreted mammalian member of the Ly-6/uPAR protein superfamily.

Authors:  K Adermann; F Wattler; S Wattler; G Heine; M Meyer; W G Forssmann; M Nehls
Journal:  Protein Sci       Date:  1999-04       Impact factor: 6.725

3.  A peptide inhibitor of cytomegalovirus infection from human hemofiltrate.

Authors:  Eva Maria Borst; Ludger Ständker; Karen Wagner; Thomas F Schulz; Wolf-Georg Forssmann; Martin Messerle
Journal:  Antimicrob Agents Chemother       Date:  2013-07-15       Impact factor: 5.191

4.  Isolation and biochemical characterization of LEAP-2, a novel blood peptide expressed in the liver.

Authors:  Alexander Krause; Rannar Sillard; Burkhard Kleemeier; Enno Klüver; Erik Maronde; José Ramon Conejo-García; Wolf Georg Forssmann; Peter Schulz-Knappe; Michael C Nehls; Frank Wattler; Sigrid Wattler; Knut Adermann
Journal:  Protein Sci       Date:  2003-01       Impact factor: 6.725

5.  IGF-binding protein-3 fragments in plasma of a child with acute renal failure.

Authors:  Victoria Schebek-Fürstenberg; Ludger Ständker; Martin Oppermann; Dirk E Müller-Wiefel; Wilfried Hahn; Werner F Blum; Thomas Braulke; Bernd Kübler
Journal:  Pediatr Nephrol       Date:  2004-12       Impact factor: 3.714

6.  Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties.

Authors:  M Detheux; L Ständker; J Vakili; J Münch; U Forssmann; K Adermann; S Pöhlmann; G Vassart; F Kirchhoff; M Parmentier; W G Forssmann
Journal:  J Exp Med       Date:  2000-11-20       Impact factor: 14.307

7.  Proteomic profiling of the thrombin-activated canine platelet secretome (CAPS).

Authors:  Signe E Cremer; James L Catalfamo; Robert Goggs; Stefan E Seemann; Annemarie T Kristensen; Marjory B Brooks
Journal:  PLoS One       Date:  2019-11-13       Impact factor: 3.240

Review 8.  Discovery of modulators of HIV-1 infection from the human peptidome.

Authors:  Jan Münch; Ludger Ständker; Wolf-Georg Forssmann; Frank Kirchhoff
Journal:  Nat Rev Microbiol       Date:  2014-08-11       Impact factor: 60.633

9.  A Fibrinogen Alpha Fragment Mitigates Chemotherapy-Induced MLL Rearrangements.

Authors:  Julia Eberle; Rahel Stefanie Wiehe; Boris Gole; Liska Jule Mattis; Anja Palmer; Ludger Ständker; Wolf-Georg Forssmann; Jan Münch; J Christof M Gebhardt; Lisa Wiesmüller
Journal:  Front Oncol       Date:  2021-06-18       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.